Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 57, Issue 3, Pages 470-479
Publisher
Oxford University Press (OUP)
Online
2017-11-05
DOI
10.1093/rheumatology/kex395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins
- (2017) Venkat Reddy et al. ARTHRITIS CARE & RESEARCH
- The BAFFling effects of rituximab in lupus: danger ahead?
- (2016) Michael R. Ehrenstein et al. Nature Reviews Rheumatology
- OP0029 The Risk of Serious Infections in Patients Receiving Rituximab for Rheumatoid Arthritis: Table 1
- (2014) L. Silva-Fernandez et al. ANNALS OF THE RHEUMATIC DISEASES
- The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012
- (2014) Frances Rees et al. ANNALS OF THE RHEUMATIC DISEASES
- Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
- (2014) Ian N Bruce et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review
- (2014) Tatiana Cobo-Ibáñez et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
- (2013) Daniel J Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab in systemic lupus erythematosus: an updated systematic review and meta-analysis
- (2013) B Duxbury et al. LUPUS
- All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre
- (2013) J. Lee et al. RHEUMATOLOGY
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
- (2011) Cándido Díaz-Lagares et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen
- (2011) A. N. Ezeonyeji et al. RHEUMATOLOGY
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Numerical scoring for the BILAG-2004 index
- (2010) Chee-Seng Yee et al. RHEUMATOLOGY
- A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients
- (2009) Tim Y.-T. Lu et al. ARTHRITIS AND RHEUMATISM
- Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
- (2009) Johan Askling et al. ARTHRITIS AND RHEUMATISM
- Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry
- (2009) Merete Lund Hetland et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality
- (2009) F Goldblatt et al. LUPUS
- Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases
- (2009) M Ramos-Casals et al. LUPUS
- Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
- (2009) S. A. Chambers et al. RHEUMATOLOGY
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The British Society for Rheumatology Biologics Register: 6 years on
- (2008) K. L. Hyrich et al. RHEUMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search